Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Identification of two potential whale calls in the southern Indian Ocean, and their geographic and seasonal occurrence.

Leroy EC, Samaran F, Bonnel J, Royer JY.

J Acoust Soc Am. 2017 Sep;142(3):1413. doi: 10.1121/1.5001056.

PMID:
28964059
2.

Seasonal and Diel Vocalization Patterns of Antarctic Blue Whale (Balaenoptera musculus intermedia) in the Southern Indian Ocean: A Multi-Year and Multi-Site Study.

Leroy EC, Samaran F, Bonnel J, Royer JY.

PLoS One. 2016 Nov 9;11(11):e0163587. doi: 10.1371/journal.pone.0163587. eCollection 2016.

3.

Low-frequency sound level in the Southern Indian Ocean.

Tsang-Hin-Sun E, Royer JY, Leroy EC.

J Acoust Soc Am. 2015 Dec;138(6):3439-46. doi: 10.1121/1.4936855.

PMID:
26723301
4.

Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia.

LeRoy EC, Moore JH, Hu C, Martínez ME, Lance P, Duggan D, Thompson PA.

Hum Genet. 2011 May;129(5):503-12. doi: 10.1007/s00439-010-0942-0. Epub 2011 Jan 11.

PMID:
21221997
5.

Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study.

Jacobs ET, Thomson CA, Flatt SW, Al-Delaimy WK, Hibler EA, Jones LA, Leroy EC, Newman VA, Parker BA, Rock CL, Pierce JP.

Am J Clin Nutr. 2011 Jan;93(1):108-17. doi: 10.3945/ajcn.2010.30009. Epub 2010 Oct 27.

6.

Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry.

Jacobs ET, Martínez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW, LeRoy EC, Poynter JN, Thompson PA, Baron JA.

Carcinogenesis. 2010 Aug;31(8):1412-6. doi: 10.1093/carcin/bgq127. Epub 2010 Jun 17.

7.

Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.

Hibler EA, Jurutka PW, Egan JB, Hu C, LeRoy EC, Martinez ME, Thompson PA, Jacobs ET.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):438-41. doi: 10.1016/j.jsbmb.2010.03.052. Epub 2010 Mar 20.

8.

Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.

Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, Jurutka PW, Leroy EC, Martínez ME, Mount D, Jacobs ET.

Cancer Res. 2010 Feb 15;70(4):1496-504. doi: 10.1158/0008-5472.CAN-09-3264. Epub 2010 Feb 9.

9.

The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

Markiewicz M, Smith EA, Rubinchik S, Dong JY, Trojanowska M, LeRoy EC.

Clin Exp Rheumatol. 2004 Jan-Feb;22(3 Suppl 33):S31-4.

PMID:
15344595
10.

Natural history of asymptomatic left ventricular systolic dysfunction in the community.

Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS.

Circulation. 2003 Aug 26;108(8):977-82. Epub 2003 Aug 11.

11.

The role of infectious agents in the pathogenesis of systemic sclerosis.

Hamamdzic D, Kasman LM, LeRoy EC.

Curr Opin Rheumatol. 2002 Nov;14(6):694-8. Review.

PMID:
12410093
12.

A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

Pandey JP, LeRoy EC.

Ann Rheum Dis. 2002 Aug;61(8):671-2. No abstract available.

13.

Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted.

Pandey JP, Page GP, Silver RM, LeRoy EC, Bona CA.

Exp Clin Immunogenet. 2001;18(3):123-9.

PMID:
11549841
14.

MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts.

Hamamdzic D, Harley RA, Hazen-Martin D, LeRoy EC.

BMC Musculoskelet Disord. 2001;2:3. Epub 2001 Jul 31.

15.

Criteria for the classification of early systemic sclerosis.

LeRoy EC, Medsger TA Jr.

J Rheumatol. 2001 Jul;28(7):1573-6. Review.

PMID:
11469464
16.

Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins.

Vaughan JH, Shaw PX, Nguyen MD, Medsger TA Jr, Wright TM, Metcalf JS, Leroy EC.

J Rheumatol. 2000 Mar;27(3):821-3. No abstract available.

PMID:
10743836
17.

Autoimmunity and vascular involvement in systemic sclerosis (SSc).

Kahaleh MB, LeRoy EC.

Autoimmunity. 1999;31(3):195-214. Review.

PMID:
10739336
18.

A disease severity scale for systemic sclerosis: development and testing.

Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, Krieg T, Leroy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H.

J Rheumatol. 1999 Oct;26(10):2159-67.

PMID:
10529133
19.

Thrombospondin 1 is expressed by mesenchymal cells in mouse post-natal skin and hair follicle development.

Pablos JL, Everett ET, Leroy EC, Norris JS.

Histochem J. 1998 Jul;30(7):461-5.

PMID:
10192528
20.

Identification of altered expression of ADP/ATP translocase during cellular senescence in vitro.

Fan W, Kou H, Shen D, LeRoy EC.

Exp Gerontol. 1998 Aug;33(5):457-65.

PMID:
9762523
21.

Pathogenesis of fibrosis: type 1 collagen and the skin.

Trojanowska M, LeRoy EC, Eckes B, Krieg T.

J Mol Med (Berl). 1998 Mar;76(3-4):266-74. Review.

PMID:
9535560
22.

Diseases of the extracellular matrix.

Krieg T, LeRoy EC.

J Mol Med (Berl). 1998 Mar;76(3-4):224-5. No abstract available.

PMID:
9535556
23.

Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis.

Pandey JP, LeRoy EC.

Arthritis Rheum. 1998 Jan;41(1):10-5. Review. No abstract available.

PMID:
9433864
24.

Oncostatin M stimulates transcription of the human alpha2(I) collagen gene via the Sp1/Sp3-binding site.

Ihn H, LeRoy EC, Trojanowska M.

J Biol Chem. 1997 Sep 26;272(39):24666-72.

25.
26.

Scleroderma and related conditions.

Mitchell H, Bolster MB, LeRoy EC.

Med Clin North Am. 1997 Jan;81(1):129-49. Review.

PMID:
9012758
28.

IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts.

Makhluf HA, Stepniakowska J, Hoffman S, Smith E, LeRoy EC, Trojanowska M.

J Invest Dermatol. 1996 Dec;107(6):856-9.

29.

Systemic sclerosis. A vascular perspective.

LeRoy EC.

Rheum Dis Clin North Am. 1996 Nov;22(4):675-94. Review.

PMID:
8923590
30.
31.

Paul Klee and scleroderma.

LeRoy EC, Silver RM.

Bull Rheum Dis. 1996 Oct;45(6):4-6. No abstract available.

PMID:
8885478
32.

Sexual function and erection capability among young men with spina bifida.

Sandler AD, Worley G, Leroy EC, Stanley SD, Kalman S.

Dev Med Child Neurol. 1996 Sep;38(9):823-9.

PMID:
8810714
33.
34.

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.

Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, Leroy EC, Fritzler MJ.

Arthritis Rheum. 1996 Jul;39(7):1151-60.

PMID:
8670324
35.

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.

Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM.

J Rheumatol. 1995 Oct;22(10):1876-83.

PMID:
8991985
36.

Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse.

Pablos JL, Everett ET, Harley R, LeRoy EC, Norris JS.

Lab Invest. 1995 Jun;72(6):670-8.

PMID:
7783425
37.
38.

Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.

White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, Lachenbruch PA, LeRoy EC, Mitrane MP, Paulus HE, et al.

Arthritis Rheum. 1995 Mar;38(3):351-60.

PMID:
7880189
39.

The role of mast cells in the development of skin fibrosis in tight-skin mutant mice.

Everett ET, Pablos JL, Harley RA, LeRoy EC, Norris JS.

Comp Biochem Physiol A Physiol. 1995 Feb;110(2):159-65.

PMID:
7704626
41.

The immunopathogenesis of systemic sclerosis. Introduction.

Korn JH, LeRoy EC.

Int Rev Immunol. 1995;12(2-4):i-v. No abstract available.

PMID:
7650415
42.

Sexual knowledge and experience among young men with spina bifida.

Sandler AD, Worley G, Leroy EC, Stanley SD, Kalman S.

Eur J Pediatr Surg. 1994 Dec;4 Suppl 1:36-7. No abstract available.

PMID:
7766552
43.

Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene).

Waller PA, Clauw D, Cupps T, Metcalf JS, Silver RM, Leroy EC.

J Rheumatol. 1994 Aug;21(8):1567-70.

PMID:
7983667
44.

Cytokines and systemic sclerosis.

Fagundus DM, Leroy EC.

Clin Dermatol. 1994 Jul-Sep;12(3):407-17. Review. No abstract available.

PMID:
7954198
45.
46.

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor.

Ohba T, McDonald JK, Silver RM, Strange C, LeRoy EC, Ludwicka A.

Am J Respir Cell Mol Biol. 1994 Apr;10(4):405-12.

PMID:
7510986
47.
48.

The tight-skin (Tsk) mutation is closely linked to B2m on mouse chromosome 2.

Everett ET, Pablos JL, Harris SE, LeRoy EC, Norris JS.

Mamm Genome. 1994 Jan;5(1):55-7. No abstract available.

PMID:
8111131
49.

A dialogue for the management of common musculoskeletal disorders.

LeRoy EC.

J S C Med Assoc. 1993 Nov;89(11):546-7. No abstract available.

PMID:
8258971
50.

Raynaud's phenomenon and connective tissue diseases.

Waller PA, Leroy EC.

J S C Med Assoc. 1993 Nov;89(11):536-42. No abstract available.

PMID:
8258970

Supplemental Content

Loading ...
Support Center